The main objective of country-level consultations is to provide an opportunity to discuss a joint position among the government institutions, public health, law enforcement and civil society stakeholders for the UNGASS 2016 on the World Drug Problem. This joint position can be reflected in country’s statements during the UNGASS 2016 on World Drug Problem, as well as the 59th session of the Commission on Narcotic Drugs (CND).
Training module and manual was developed in response to drug‑related deaths and overdoses upon release from prison. It aims to increase (evidence-based) knowledge and skills in overdose prevention and management and improve awareness of good practice models. The module relates to the documents, developed within the same project: "Overdose Prevention Services Upon Release from Prison: Estonia, Lithuania, Hungary, Poland and Romania" and “Overdose Prevention Services upon Release from Prison: Best Practices from Scotland, Denmark, Italy and Spain”. As such, these reports should be read in conjunction with the both, the training module and manual in order to enhance understanding, whilst accessing other useful information and research references listed.
The training module is aimed to increase individual capacity and quality by building upon specific skills, in order to ensure that harm reduction services providers can comprehensively scale-up services being offered to women who use drugs.
This training toolkit has been developed by the International Drug Policy Consortium (IDPC) and the Eurasian Harm Reduction Network (EHRN) to build the capacity of civil society organisations for engaging with, and influencing, drug policy making processes. This toolkit can be used by anybody wishing to deliver trainings and workshops on drug policy advocacy to their civil society partners and members. It covers the areas of drug policy, civil society advocacy and harm reduction, and is intended as a comprehensive menu of activities and content from which a facilitator can pick and choose the ones which best suit the context, audience and timeframe.
This manual aims to contribute to the comprehensive response to HIV, TB and drug use and support linkages between HIV prevention, TB control and harm reduction strategies and services in Eastern Europe and Central Asia. It compiles clinical and programmatic information about TB, HIV and drug use aligned with the most recent normative guidance issued by WHO. The goal of the manual is to increase the capacity to provide quality TB-related services for people who inject drugs and are living with HIV. Although the training manual might be useful for all stakeholders involved in harm reduction and TB programs as an information resource, it is primarily designed for trainers developing and delivering trainings to civil society, community and health care workers in the field of harm reduction, TB and HIV.
Данная публикация неправительственной организации "ЮЛА" освещает проблематику тройного диагноза (наркозависимость, ВИЧ/СПИД, туберкулез) и необходимость интегрированного подхода в системе существующих структур здравоохранения Российской Федерации. Сборник статей включает статьи по трем заболеваниям: туберкулез, ВИЧ, опиоидная зависимость. Он является одной из первых попыток представить российским врачам- фтизиатрам, инфекционистам, психиатрам-наркологам проблематику ситуации и предоставить информацию о современных методах лечения ТБ, ВИЧ и опиоидной зависимости с учетом специфики тройного диагноза. Сборник предназначен прежде всего для врачей-фтизиатров, инфекционистов, психиатров-наркологов, но будет также полезен всем специалистам, которые работают в этой области.
This training manual has been written for people who are responsible for delivering HCV treatment and care with people who inject drugs PWID, including those working in harm reduction, drug treatment or other health and social care services. PWID who fulfil an advocacy role are – themselves – also a vital audience for this resource. The manual is structured around a three day learning programme with modules that: introduce HCV, its transmission and prevention; examine the diagnostic tests and treatments that are used and the evidence that underpins these; considers the issues that arise in the case of co-infection with HIV; and, promotes reflection on some of the key organisational, practice and policy issues that affect the provision of HCV treatment and care. Although there is an underlying three-day structure, the programme is modular and intended to be used and adapted in line with people’s needs, the local situation and the opportunities and resources available.
The revised edition of theWHO UNODC UNAIDS Technical Guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users(Guide) is now available and has a number of OST quality indicators increased up to 26. Among others, such important quality indicators as involvement of people who use drugs (“The programme has actively involved PWID in the planning of OST services”) and established referral systems (“Formalized referral pathways between the OST programme and other relevant service providers have been established, and OST clients are referred to these services as appropriate”) are included.
Informed decision-making for harm reduction funding requires a good costing exercise. The UNAIDS Workbook for the Collection of Cost Information on HIV Facilities and Services is a companion publication to the Manual for Costing HIV Facilities and Services. The Workbook explains the data collection and analysis process for calculating the unit costs of providing services at the facility level and the programmatic costs associated with providing services for a single facility.